Jagiellonian University Repository

Mammotome biopsy in the diagnostic management of non-palpable breast pathologies

Mammotome biopsy in the diagnostic management of ...

Show full item record

dc.contributor.author Popiela, Tadeusz [SAP20001360] pl
dc.contributor.author Tabor, Jacek pl
dc.contributor.author Chrzan, Robert [SAP20001365] pl
dc.contributor.author Podsiadło-Kleinrok, Beata pl
dc.contributor.author Urbanik, Andrzej [SAP20001269] pl
dc.date.accessioned 2019-08-16T07:36:03Z
dc.date.available 2019-08-16T07:36:03Z
dc.date.issued 2006 pl
dc.identifier.issn 1733-134X pl
dc.identifier.uri https://ruj.uj.edu.pl/xmlui/handle/item/80816
dc.language eng pl
dc.rights Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa *
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/pl/legalcode *
dc.title Mammotome biopsy in the diagnostic management of non-palpable breast pathologies pl
dc.title.alternative Biopsja mammotomiczna w diagnostyce niepalpacyjnych zmian patologicznych piersi pl
dc.type JournalArticle pl
dc.description.physical 48-56 pl
dc.description.additional Bibliogr. s. 56 pl
dc.identifier.weblink http://archiwum.inforadiologia.pl/download/index/idArt/456668.html pl
dc.abstract.en Background: The aim of the study was to determine the effectiveness of mammotome biopsy (MB) in detecting preclinical breast pathologies. Material/Methods: The material consisted of 847 women, of whom, based on mammography and ultrasound, 349 patients were referred to have stereotactic mammotome biopsy (SMB) guided by digital mammography and 498 women were subjected to hand-held mammotome biopsy (HHMB) guided by US. Results: Ultimately, MB was done in 819 women. In all cases where breast carcinoma or atypical ductal hyperplasia (ADH) were detected, the patients were operated on and postoperative histopathology was treated as the reference for post-biopsy histopathology. Patients in whom post-MB histopathology detected benign lesions were subjected to a strict long-term follow-up using imaging studies. Ultimately, thanks to MB, 94 cases of breast cancer (12%) were detected as well as 725 (88%) cases of benign lesions, which corresponds to a sensitivity of 98.9% and 100% specificity. Conclusions: MB is an alternative to surgical biopsy in differentiating preclinical breast lesions. It is associated with a minimal risk of complications and may be successfully performed in an outpatient setting. pl
dc.subject.en mammotome biopsy pl
dc.subject.en vacuum assisted core needle biopsy pl
dc.subject.en pre-clinical cancers: non-palpable breast lesions pl
dc.description.volume 71 pl
dc.description.number 3 pl
dc.identifier.eissn 1899-0967 pl
dc.title.journal Polish Journal of Radiology pl
dc.language.container pol pl
dc.date.accession 2019-08-16 pl
dc.affiliation Wydział Lekarski : Zakład Radiologii pl
dc.affiliation Wydział Lekarski : Klinika Chirurgii Ogólnej, Onkologicznej i Gastroenterologicznej pl
dc.subtype Article pl
dc.identifier.articleid 456668 pl
dc.rights.original CC-BY-NC-ND; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0 pl
dc.identifier.project ROD UJ / OP pl


Files in this item

This item appears in the following Collection(s)

Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa Except where otherwise noted, this item's license is described as Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa